Tripsit.ai

Where Patient Voice Meets Clinical Evidence.

Continuous Medical and Brand Readiness!

Your Scientists Are Brilliant.
We Help Them Tell the Story.

TripSit generates the deliverables pharmaceutical teams need most — patient journeys, unmet needs analyses, and brand stories — grounded in both real-world patient signals and published clinical evidence.

Our dual-path methodology runs the analysis from the patient's perspective and the science independently, then reveals where they agree and where they diverge. The convergence zones are your strongest messages. The divergence zones are your evidence generation opportunities.

From Signals to Stories, Grounded in Evidence.

Patient First
Science First
Convergence Report

Every insight labeled. Every citation verified. Every gap identified.

Built For

TripSit.ai is a competitive intelligence platform built for pharmaceutical and biotech teams, agencies, C-suite leadership, functional area leaders, commercial teams, and scientific thought leaders seeking to uncover new therapy opportunities through market intelligence.

The platform is especially invaluable for rare disease therapies, uncovering patient journeys and life-changing emerging treatment opportunities that are otherwise completely undiscoverable.

Commercial Teams
Discover new positioning opportunities and market expansion strategies based on real-world patient experiences and regulatory insights
Lifecycle Management
Identify lifecycle extension opportunities and new indications through post-marketing surveillance data and patient journey analysis
HEOR Teams
Generate evidence-based value narratives and real-world data campaign strategies to support payer discussions and market access
Medical Affairs
Develop strategic narratives for HCPs and stakeholders based on regulatory filings, patient insights, and unmet needs analysis
Market Access
Understand reimbursement challenges and payer perspectives to craft compelling access strategies and value propositions
R&D Teams
Reveal new therapy applications and unmet clinical needs that emerge from market knowledge rather than laboratory research
Medical Agencies
Deliver differentiated strategic insights and patient-centric narratives to pharmaceutical clients with evidence-based storytelling
Scientific Consultancies
Accelerate real-world evidence generation and value demonstration projects with AI-powered patient journey analysis
Medical Consultancies
Enhance advisory services with data-driven insights on unmet needs, market opportunities, and strategic positioning
Why TripSit Exists

Your scientists are brilliant. They generate extraordinary evidence. What they rarely have time to do is translate that evidence into the patient journeys, unmet needs analyses, and brand narratives that guide strategy across functions.

TripSit runs two independent analytical paths — one from the patient experience, one from the published science — and reveals where they converge and where they diverge. The convergence is where your strongest brand messages live. The divergence is where your evidence generation opportunities are hiding.

How It Works

Two independent analytical paths. One convergence report. Intelligence, not search.

1

Run Patient First

Start from the patient experience. TripSit scans patient forums, social listening, and real-world signals to surface unmet needs, then goal-seeks back to published clinical evidence. The inference opens the door; the evidence tells you whether to walk through it.

2

Run Science First

Start from the published evidence. Clinical trials, FDA labels, and peer-reviewed literature form the foundation. Patient narratives are built from what the science supports, with every claim grounded and every gap clearly identified.

3

Compare the Paths

The Convergence Report shows where both paths agree — your strongest, most defensible brand messages — and where they diverge. Divergence zones reveal evidence generation opportunities: patient signals that haven't been studied yet.

4

Start the Meeting

Export patient journeys, stakeholder challenge maps, competitive positioning, and evidence packages. We start the meeting — you explore the science.

Our Evidence Architecture

Real APIs. Real Data. Transparent AI.

TripSit.ai connects to official medical databases via API and enhances analysis with AI. We're transparent about what's directly connected versus AI-generated.

These sources have direct API integrations with real-time or cached data

API Connected
ClinicalTrials.gov
Real-time access to registered clinical trials from the official NIH database. We fetch Phase 3 and Phase 4 studies with enrollment data, sponsors, and study status.

Sources

ClinicalTrials.gov API v2

Update Frequency

Real-time with 24-hour cache

Limitations

  • Trial registration may lag actual study status
  • Limited to English-language trial records
API Connected
PubMed/NCBI
Real-time access to peer-reviewed medical literature via the NCBI E-utilities API. We fetch systematic reviews, meta-analyses, and clinical trial publications.

Sources

NCBI E-utilities APIPubMed Database

Update Frequency

Real-time with 24-hour cache

Limitations

  • Abstract-level data only; full text requires journal access
  • Citation counts not available via API
API Connected
Congress Abstracts
Curated abstracts from major medical society congresses. Data is manually loaded by our team from official conference proceedings.

Sources

EADVASCOAADESMOand more...

Update Frequency

Within 2 weeks of congress conclusion

Limitations

  • Coverage depends on manual curation effort
  • Not all congresses are currently loaded
API Connected
Global Regulatory Labels
Multi-region drug labeling data via the BioCore Regulatory Platform. Covers 8 regulatory authorities including FDA DailyMed (US), MHRA (UK), EMA (EU), Health Canada, SwissMedic, TGA (Australia), ANSM (France), and PMDA (Japan).

Sources

FDA DailyMed (US)MHRA (UK)EMA (EU)Health CanadaSwissMedic (CH)TGA (AU)ANSM (FR)PMDA (JP)

Update Frequency

Real-time with local database sync

Limitations

  • Label availability varies by region and product age
  • Some older labels may have limited structured data
API Connected
Biochemical Repositories
Molecular, chemical, and translational science data via the BioCore platform. Includes protein sequences, bioactive molecules, chemical classification, and drug interaction data from 7 specialized databases.

Sources

OpenFDA UNIINCATSUniProtChEMBLDrugCentralPubChemClassyFire

Update Frequency

Synced via BioCore platform updates

Limitations

  • Molecular data depth varies by compound novelty
  • Some newer biologics may have limited chemical classification
API Connected
Medical News RSS
Real-time aggregation of medical and pharmaceutical news from official RSS feeds including FDA, EMA, NIH, CDC, and PubMed Trending.

Sources

FDA Press ReleasesFDA Drug SafetyEMA NewsNIH NewsCDC NewsroomPubMed Trending

Update Frequency

Real-time

Limitations

  • Limited to sources with public RSS feeds
  • Article summaries only; full text requires visiting source
API Connected
Social & Patient Voice
Real patient discussions and sentiment from healthcare communities across Reddit, Twitter/X, YouTube, TikTok, LinkedIn, disease society sites, and manufacturer patient portals.

Sources

Reddit APITwitter/X APIYouTube Data APITikTok Research APILinkedIn APIDisease Society Sites

Update Frequency

Real-time with each insight generation

Limitations

  • Sentiment analysis uses keyword matching, not advanced NLP
  • Twitter/X and TikTok APIs may have rate limits
API Connected
FDA FAERS (Adverse Event Reporting)
Direct API integration with FDA's Adverse Event Reporting System (FAERS) via OpenFDA. Provides post-marketing safety surveillance data including adverse event frequencies, serious outcome rates, and reporting trends.

Sources

FDA FAERS via OpenFDA APIPost-Marketing Safety ReportsMedWatch Voluntary Reports

Update Frequency

Real-time API queries; FAERS database updated quarterly by FDA

Limitations

  • Voluntary reporting system — does not capture all adverse events
  • Reports do not establish causation between drug and adverse event
API Connected
CMS HCAHPS Patient Experience
Direct API integration with CMS Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey data. Provides national patient experience benchmarks.

Sources

CMS Provider Data APIHCAHPS National Survey ResultsHospital Compare Data

Update Frequency

Real-time API queries; CMS updates survey data annually

Limitations

  • National benchmarks — not drug-specific or therapy-area-specific
  • Survey data reflects hospital-level experience, not outpatient/specialty care
API Connected
Real-World Evidence Registries
Aggregated real-world evidence from post-marketing clinical trials, FDA safety databases, patient voice signals, and observational study publications.

Sources

ClinicalTrials.gov Phase 4 StudiesFDA Post-Marketing SupplementsBioCore Safety UpdatesPatient Voice SignalsPubMed Observational Studies

Update Frequency

Real-time with each insight generation; safety data synced daily

Limitations

  • RWE signals are aggregated from existing sources, not from direct claims or EHR databases
  • Patient-reported outcomes may not be representative of full patient population
AI Synthesis
Meeting-Ready Insights

We combine real API data with AI analysis to surface signals that start meetings — patient journeys, unmet needs, and brand opportunities your scientists can't tell.

Getting Started

Begin discovering new opportunities in minutes

1. Sign Up

Create your account in seconds using secure authentication. No credit card required to start exploring.

2. Submit Your First Query

Define your product type and focus area. Our intuitive form guides you through the process in under a minute.

3. Discover Insights

Review AI-generated insights, explore patient journeys, and access strategic recommendations tailored to your team's needs.

Platform Capabilities

Insights
Find the signals that start your next program. Search across patient forums, clinical evidence, and regulatory filings.
Congresses
Ground every signal in evidence. Cross-reference against congresses, trials, guidelines, and the Big Six evidence streams.
Build
Generate competitive intelligence, patient journeys, unmet needs analyses, and brand narratives — the deliverables your team needs to start the meeting.
Pipeline Intelligence
Analyze on-market therapies from the top 20 Pharma company pipelines, track social sentiment, and get strategic recommendations based on science momentum and new meeting Congress data.
Multi-Lens Analysis
View signals through different stakeholder lenses—payer, provider, health system—to understand full market dynamics.
Evidence Architecture
Every insight grounded in the Big Six: congresses, trials, regulatory drug labels, guidelines, literature, and real-world data.

Meet the Founder

Built by healthcare industry experts who understand your challenges

Bob Battista - Founder & CEO
Bob Battista

Founder & CEO

Bob brings extensive experience in healthcare marketing and technology, with a vision to transform how healthcare professionals leverage data and AI to generate actionable insights. His deep understanding of regulatory landscapes and patient engagement drives Tripsit.ai's mission to empower marketing teams with innovative intelligence tools.

WeHealth

Part of the TripSit.ai Family of Services

Every month, 70 million insurance coverage denials are issued in the U.S. WeHealth helps patients, caregivers, and healthcare professionals fight back with evidence-based appeal letters grounded in clinical guidelines, peer-reviewed research, and applicable legal protections.

Medical Evidence

20-30 citations per letter from peer-reviewed sources

Patient Preferences

Supporting the patient's right to choose their care

Clinical Judgment

Backing the prescribing physician's expertise

See Where Patient Voice Meets Clinical Evidence

Two paths. One truth. Discover where your brand story is strongest — and where you need more evidence.